Federated Hermes Inc. Lowers Stake in Maximus, Inc. $MMS

Federated Hermes Inc. reduced its stake in shares of Maximus, Inc. (NYSE:MMS) by 22.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 679,658 shares of the health services provider’s stock after selling 201,130 shares during the period. Federated Hermes Inc. owned approximately 1.21% of Maximus worth $47,712,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in MMS. Parkside Financial Bank & Trust lifted its stake in Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after purchasing an additional 157 shares during the last quarter. Verus Financial Partners Inc. raised its holdings in shares of Maximus by 6.7% during the 2nd quarter. Verus Financial Partners Inc. now owns 3,387 shares of the health services provider’s stock valued at $244,000 after buying an additional 214 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the last quarter. UMB Bank n.a. boosted its stake in Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock worth $58,000 after buying an additional 227 shares in the last quarter. Finally, Exchange Traded Concepts LLC grew its position in Maximus by 2.0% during the second quarter. Exchange Traded Concepts LLC now owns 11,870 shares of the health services provider’s stock valued at $833,000 after acquiring an additional 228 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Stock Down 1.6%

Shares of NYSE MMS opened at $83.31 on Tuesday. The firm’s fifty day moving average is $85.31 and its 200 day moving average is $80.49. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $92.50. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77. The company has a market cap of $4.54 billion, a price-to-earnings ratio of 14.98 and a beta of 0.56.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period last year, the business earned $1.46 EPS. Maximus’s revenue was up .2% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Friday, November 14th. Maximus’s payout ratio is currently 21.58%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MMS. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, December 2nd. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Maximus has a consensus rating of “Moderate Buy” and an average price target of $90.00.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total value of $350,746.76. Following the completion of the sale, the insider owned 19,542 shares in the company, valued at approximately $1,697,027.28. This trade represents a 17.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.